Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Reexamination Certificate
2008-04-01
2008-04-01
Tate, Christopher R (Department: 1655)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
C514S266400, C514S256000, C514S252170
Reexamination Certificate
active
07351567
ABSTRACT:
The present invention relates to a process for preparing 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen-2-ol compounds useful as an estrogen agonist.
REFERENCES:
patent: 4808605 (1989-02-01), Branca et al.
patent: 5106750 (1992-04-01), Wong et al.
patent: 5248609 (1993-09-01), Petzoldt et al.
patent: 5552412 (1996-09-01), Cameron et al.
patent: 5714642 (1998-02-01), Didion et al.
patent: 6180375 (2001-01-01), Truesdell
patent: 0357009 (1990-03-01), None
patent: 0989187 (2000-03-01), None
patent: WO 8803570 (1987-11-01), None
patent: WO 9621656 (1996-07-01), None
patent: WO 9716434 (1997-05-01), None
patent: WO 9858073 (1998-12-01), None
patent: WO 9965486 (1999-12-01), None
Organic Letters, vol. 2, No. 25, pp. 4025-4027; (2000).
Lee, et al., “Enzymatic Resolution of Racemic Ibuprofen Esters: Effects of Organic Cosolvents and Temperature”,Journal of Fermentation and Bioengineering80(6), pp. 613-615 (1995), XP009022668.
Xie, et al., “Candida rugosa lipase catalyzed esterification of racemic ibuprofen with butanol; racemization of R-ibuprofen and chemical hydrolysis of S-ester formed”,Biotechnology Letters20(5), pp. 455-458 (1998), XP009022661.
Benson Gregg C.
Pfizer Inc.
Tate Christopher R
Wichtowski John A.
Winston Randall
LandOfFree
Enzymatic resolution of selective estrogen receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enzymatic resolution of selective estrogen receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzymatic resolution of selective estrogen receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2749750